Abstract: The present invention relates to the field of pharmaceutical synthesis. Disclosed is a long-lasting hepatitis virus entry inhibitor. The long-lasting hepatitis virus entry inhibitor of the present invention is used for preparing a pharmaceutical composition for treating diseases, the pharmaceutical composition being used for treating chronic hepatitis B and hepatitis D.

Abstract: The present invention is a hybrid energy storage battery status monitoring method and system based on big data processing. The method aims at the non-linear and difficult online evaluation problems of the hybrid energy storage battery status. It is set up to collect charging sample information and discharge sample information in sequence. Steps include data sorting and fusion steps, hybrid energy storage battery SOH estimation steps, and hybrid energy storage battery health level evaluation steps to implement business hybrid energy storage battery status monitoring. Among them, the sample data information elements include voltage and current in the charge and discharge state, power, temperature, internal resistance, through data collection and fusion processing, and data prediction through preset models, it can fully cover the hybrid energy storage battery status, conduct a comprehensive assessment, and improve the accuracy of the assessment.

Abstract: The present invention designs a fault diagnosis method and system for energy storage power stations based on distributed neural networks. The method includes: obtaining the operating data of various batteries in each energy storage station, and performing preprocessing operations on the data, including data cleaning. and standardization; obtain the diagnostic data of the corresponding energy storage station based on the data preprocessing results; input the preprocessed diagnostic data into the pretrained distributed neural network to diagnose the fault of the energy storage power station. The technical solution proposed in this application can accurately diagnose energy storage power station faults and improve the maintenance efficiency of energy storage power stations.

Abstract: The invention relates to the field of medicine synthesis, and a GLP-1 compound is disclosed. Also disclosed are the use of the GLP-1 compound for preparing a pharmaceutical composition for treating diseases, and the use of the pharmaceutical composition in the preparation of drugs for treating at least one of the following diseases. The diseases include type I diabetes, impaired glucose tolerance, type I diabetes, obesity, hypertension, metabolic syndrome, dyslipidemia, cognitive disorder, atherosclerosis, myocardial infarction, coronary artery heart disease, cardiovascular disease, stroke, inflammatory bowel syndrome and/or dyspepsia or gastric ulcer, hepatic fibrosis disease and pulmonary fibrosis disease.

Abstract: The present invention relates to the field of pharmaceutical synthesis, and disclosed is an exenatide analog. The exenatide analog is used for preparing a pharmaceutical composition for treating diseases. Also disclosed is a use of the pharmaceutical composition in preparation of medicines for treating at least one of the following diseases: type-II diabetes, impaired glucose tolerance, type-I diabetes, obesity, hypertension, metabolic syndrome, dyslipidemia, cognitive disorder, atherosclerosis, myocardial infarction, coronary heart disease, cardiovascular diseases, stroke, inflammatory bowel syndrome and/or dyspepsia or gastric ulcer, hepatic fibrosis diseases, and pulmonary fibrosis diseases.